Titre:
  • 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Auteur:Cameron, David A; Gianni, Luca; Baselga, José; Al-Sakaff, Nedal; Lauer, Sabine; McFadden, Eleanor; Leyland-Jones, Brian; Bell, Richard; Dowsett, Mitch; Jackisch, Christian; Piccart-Gebhart, Martine; Gelber, Richard; Procter, Marion; Goldhirsch, Aron; Azambuja, Evandro; Castro, Gilberto; Untch, Michael; Smith, Ian I.E.
Informations sur la publication:Lancet, 389, 10075, page (1195-1205)
Statut de publication:Publié, 2017-03
Sujet CREF:Sciences bio-médicales et agricoles
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0140-6736
info:doi/10.1016/S0140-6736(16)32616-2
info:pii/S0140673616326162
info:scp/85013031141